Globally, these results reflect the percentages of organs involvements observed in other IgAV reported cases, except from the lower rate of arthralgias detected in COVID-19-associated-IgA (43%) respect to typical HSP (up to 84%) [10]. This evidence concerns the gene CD79A and COVID-19.